Table of contents
- List of tables
- Acknowledgements
- Summary
- Introduction
- Background
- Public health significance of hepatitis B
- Economic literature on hepatitis B
- Methodology
- Identification of cost categories
- Prevalence and incidence approaches
- Results
- Hepatitis B costs (excluding chronic sequelae)
- Costs of chronic sequelae of hepatitis B
- Discussion
- Use of cost-of-illness studies
- Limitations of this study
- Australian and international cost comparisons
- Australian studies on cost-effectiveness of screening and vaccination for hepatitis B
- Hepatitis B references
- General references
- Appendix A Methodology for estimates of direct costs
- Appendix B Methodology for estimation of indirect costs
- Appendix C Supporting tables showing gender and age detail on the disease costs of hepatitis Bin 1989-90 (excluding prevention)
- Appendix D Department of Veterans' Affairs-Specialist utilisation and costs